Achyc2002's Posts
Nairaland Forum › Achyc2002's Profile › Achyc2002's Posts
1 2 3 4 5 6 7 8 9 (of 9 pages)
Pls friends, someone should put me through on how to delete a post on NL. Pls, is very urgent |
400k cash and carry |
WhoBeThisMan:Are u talking abt importing into nigeria or exporting out of nigeria? Cos I have someone dat export |
Everybody want to talk. Everybody dey look for favour. God is watching everyone of you. |
[quote author=literarymathy post=33449329]University of Ado Ekiti (UNAD) has advertised her postgraduate admissions too. The deadline is May 22nd and forms can be gotten from the banks within the school. Read more here http://unad.edu.ng I heard they are kinda slow. |
My Tutors/Gurus/Teachers/Experts in the house, pls I need you to help me with a good website/store I can get a real/genuine jewelries. Thank you very much. |
Where is d pics? |
How much is it? |
371 |
Pls, can NCE holder apply? |
Bycares:Abt one or two more but it can't be more than two. Congrat. |
Watz d range of offer u can consider so a to relate it to my client |
Plss, do u have anyone to sell, a client of mine is in need of a nigerian used one. |
Can NCE apply? |
Gguy4real: Anyone who is ready to sell bb bold 5. Pls hola me I need itHow much? |
Got this from internet. FDA allows limited use of Ebola drug. Stock spikes August 08 NEW YORK The company behind a potential Ebola drug is red-hot again. Canadian biotech firm Tekmira Pharmaceuticals (TKMR)announced that the Federal Drug Administration knocked down a key barrier to its medicine, TKM Ebola, reaching some patients. The FDA moved the drug from a "full hold" to a "partial hold," which means Tekmira can use the drug in limited experiments. Investors have been keen to find a way to put money into an Ebola cure. Shares jumped as much as 40% in recent days as news of Tekmira's drug became widely known. But the stock fell back after officials at the Emory University hospital treating two Ebola patients used another company's drugs. Investors think the drug could still become a big moneymaker for Tekmira, and the FDA upgrade in status is being viewed as added confirmation of the potential for the treatment. Jason Kolbert, an analyst with the Maxim Group, told CNNMoney earlier this week that Ebola's sudden and rapid spread moved federal officials to try out a number of Ebola treatments in development, so Tekmira still has a shot at a payday. Source: http://money.cnn.com/2014/08/08/investing/ebola-drug-approval-tekmira/index.html Is it possible that this so called spread of virus can be a business strategy for a/some company somewhere? Doing this to maximize profit and recoup their investment. |
There is something I know for sure, every problem is always accompanied by its solution. |
Saw this and just thought I should share (CNN) - Donald Trump is tweeting that "We should not be importing (Ebola) to our homeland." An Indiana congressman is worried that refugee children from Central America could pose a public health risk with "Ebola circulating." And the Twitter-sphere is filled with people asking "how can we bring these patients to America," complaining that "We don't have enough problems in America! Let's import Ebola patients!" and speculating that treating them here is "highly irresponsible." It's a terrifying disease for sure. It typically kills 90% of the people who get it, and this most recent outbreak is the largest in history. But you don't need to panic, experts say, and you definitely don't have to worry about the two American Ebola patients who are being treated in Atlanta. Here are five reasons why: 1. It's fragile. Ebola is an incredibly fragile virus. It does not fly through the air with the greatest of ease. It cannot be transmitted through a cough or sneeze. It doesn't move easily from human to human like the common cold. Ebola is aggressively infectious, so people who are infected are highly likely to get sick. But it's not highly contagious. "The Ebola virus spreads through direct contact with the blood, secretions or other body fluids of ill people and indirect contact -- for example, with needles and other things that may be contaminated with these fluids," said Stephan Monroe, deputy director of the Centers for Disease Control's National Center for Emerging Zoonotic and Infectious Diseases. 2. We know how it works. Although there is no vaccine and no cure, the one real advantage we have with Ebola is that doctors know how to control it. Ebola isn't "some mystical pathogen (with) some bizarre mode of transmission," said Bruce Ribner, who oversees the special isolation unit that is treating the patients at Emory University Hospital. Common-sense hygiene can stop its spread. "Ebola is a virus that can be stopped and not spread in hospitals. The stakes are higher, but it's easily inactivated with typical hospital disinfectants," said Centers for Disease Control and Prevention Director Tom Frieden. 3. We have the resources to contain it. The two American patients with Ebola were flown to the United States in a plane outfitted with an isolation pod. They are being kept in isolation at the Emory hospital with a specialized containment ward, one of four in the country. In the containment ward, the vents are specialized. There's an intercom and plate glass that separates patients from visitors so they don't come into direct contact. There's a strict protocol on everyone and everything that goes into and out of the patient's room. Health care workers wear protective suits. But any major medical center could really take care of an Ebola patient, said William Schaffner, an expert on infectious diseases at Vanderbilt University's School of Medicine. Most ICUs have isolation rooms that are used for patients suspected to have tuberculosis, SARS, Middle East respiratory syndrome or another infectious disease. Schaffner said that not much would be different for an Ebola patient, though more stringent precautions might be taken to ensure that health care workers are following all protocols. 4. Our medical staff is ready. "We have been training for this," Ribner said of preparations for the two American Ebola patients. These doctors know how to handle Ebola and will use an abundance of caution when working with an infected person. Medical workers across the country have also been told to watch out for Ebola symptoms and question patients who have recently traveled to West Africa. They are trained to recognize Ebola cases and can quarantine them early, keeping others from coming into contact with an infected person's bodily fluids while the disease runs its course. 5. Airports are on alert. At African airports in the Ebola-affected region, passengers are being closely screened. Health experts are watching for people with high fevers. Those who have a temperature are removed and monitored while doctors test their blood for Ebola. When passengers arrive at the airport, they are required to wash their hands in a chlorinated solution. Customs agents and passport inspectors are also wearing surgical gloves when interacting with passengers. Source: http://edition.cnn.com/2014/08/05/health/ebola-dont-panic/index.html?c=&page=4 |
(CNN) - Two American missionary workers infected with the deadly Ebola virus were given an experimental drug that seems to have saved their lives. Dr. Kent Brantly was given the medication, ZMapp, shortly after telling his doctors he thought he would die, according to a source familiar with his case. Within an hour, doctors say his symptoms -- labored breathing and a widespread rash -- dramatically improved. Nancy Writebol, another missionary working with Samaritan's Purse, received two doses of the medication and has also shown significant improvement, sources say. As there is no proven treatment and no vaccine for Ebola, this experimental drug is raising lots of questions. Who makes the drug? The drug was developed by the biotech firm Mapp Biopharmaceutical Inc., which is based in San Diego. The company was founded in 2003 "to develop novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense," according to its website. Mapp Biopharmaceutical has been working with the National Institutes of Health and the Defense Threat Reduction Agency, an arm of the military responsible for weapons of mass destruction, to develop an Ebola treatment for several years. Are there other experimental Ebola drugs out there? Yes. In March, the NIH awarded a five-year $28 million grant to establish a collaboration between researchers from 15 institutions who were working to fight Ebola. "A whole menu of antibodies have been identified as potentially therapeutic, and researchers are eager to figure out which combinations are most effective and why," a news release about the grant said. Tekmira, a Vancouver-based company that has a $140 million contract with the U.S. Department of Defense to develop an Ebola drug, began Phase 1 trials with its drug in January. But the FDA recently halted the trial, asking for more information. Source: http://edition.cnn.com/2014/08/04/health/ebola-drug-questions/index.html?hpt=hp_t2 Does that mean this serum has been lying somewhere while people are dying of the virus in Africa? |
What do you think one will need to change in it and do you we get it down to Ekiti state? |
donfemo: SONY VIDEO CAMERA (cam corder)(4GB) with memory card, UP TO 9 HRS RECORDING 3MBPHow much do u wanna sell? |
Trust first. If u trust ur husband and believe in what he can do and what he can't, then the whole thing is solved. The lady in question may be an agent of destruction, u need to apply wisdom and don't be carried away by what she does. But still, always talk to your husband calmly abt it. |
He almost escape it, but still d law has is way of catching up wit pple whethere death or alive. Just do wat u knw is right. |
Pls, I need help. Am using techno P3 and don't know how to configure it for browsing. Though, mtn has sent the manual settings info to me but dnt knw hw to go abt it. Anyone wit useful info shd pls help. |
Wat a waste |